Intended for healthcare professionals

Rapid response to:

Views & Reviews

The thinking doctor’s guide to placebos

BMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39564.454502.C2 (Published 01 May 2008) Cite this as: BMJ 2008;336:1020

Rapid Response:

The placebo effect put into context

Pittrof and Rubinstein (1) make the important point that the “placebo effect” is actually an effect – people often do get better on placebo. However, most if not all of the evidence for placebo effects comes from studies where patients expected to have a reasonable chance (generally 0.5) of receiving the active treatment. There is therefore no evidence base for prescribing placebos in a standard clinical setting, which is what the authors seem to advocate.

We do not know whether placebos will have an effect if patients are aware of what they are receiving. Such studies will probably never be conducted. However, the most likely explanation for the placebo effect, particularly in mental disorders, is that it works as a proto- psychotherapy, utilising the patients’ conviction that they are being helped and mobilising their own positive resources. We still know very little about the brain mechanisms of the placebo response, but the available evidence suggests that, like psychotherapy, it partly operates through the same pathways as the relevant active drugs (2). I would therefore expect the patient’s belief that some aspect of their brain chemistry is actually being changed to be a crucial part of the placebo effect.

There may still be ways in which patients can benefit from placebos, even if they cannot be prescribed like ordinary drugs. First, in a setting that recreates the original trial, including randomisation to placebo or active treatment, but then the physician would not have control over who receives the “reduced benefits for much reduced risks” (1); second, if physicians were to deceive patients, telling them that they are receiving an active treatment when they are not, but this would face both ethical and practical challenges; third, by administering placebo-like substances in the context of a quasi-medical model such as homoeopathy, but this will only work if the patient (and probably the physician as well) believes in this model.

1) Pittrof R, Rubinstein I. The thinking doctor's guide to placebos. BMJ 2008;336:1020 2) Linden DE. How psychotherapy changes the brain--the contribution of functional neuroimaging. Mol Psychiatry 2006;11:528-38.

Competing interests: None declared

Competing interests: No competing interests

05 May 2008
David E Linden
Professor of Biological Psychiatry
School of Psychology, Bangor University and North Wales Clinical School, Bangor LL572AS